What Alexza Pharmaceuticals Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Pakianathan Deepika | Director | Jun 21 | Tender Offer · U | −98,967 | — | — | 0 |
| Pakianathan Deepika | Director | Jun 21 | Tender Offer · U | −658 | — | — | 0 |
| Read J Leighton | Director | Jun 21 | Tender Offer · U | −3,492 | — | — | 0 |
| Ringold Gordon | Director | Jun 21 | Tender Offer · U | −927 | — | — | 0 |
| Ringold Gordon | Director | Jun 21 | Tender Offer · U | −927 | — | — | 0 |
| Ringold Gordon | Director | Jun 21 | Tender Offer · U | −32,392 | — | — | 0 |
| Stein Issac | Director | Jun 21 | Tender Offer · U | −15,838 | — | — | 0 |
| Turner Joseph L | Director | Jun 21 | Tender Offer · U | −1,050 | — | — | 0 |
| King Thomas Braxton | President & CEO | Jun 21 | Tender Offer · U | −40,000 | — | — | 0 |
| King Thomas Braxton | President & CEO | Jun 21 | Tender Offer · U | −37,224 | — | — | 0 |
| Kamemoto Edwin S | EVP, R&D, Regulatory & Quality | Jun 21 | Tender Offer · U | −9,112 | — | — | 0 |
| Grupo Ferrer Internacional, S.a. | 10% owner | Jun 21 | Open-market buy · P | +19,465,714 | $0.90 | +$17.5M | 21,832,649 |
| Grupo Ferrer Internacional, S.a. | 10% owner | Sep 28 | Open-market buy · P | +125,000 | — | — | 2,366,935 |
| Grupo Ferrer Internacional, S.a. | 10% owner | Sep 28 | Open-market buy · P | +125,000 | — | — | 2,366,935 |
| Ringold Gordon | Director | Sep 06 | Open-market buy · P | +10,000 | $4.77 | +$47.7K | 32,392 |
| King Thomas Braxton | Pres & CEO | Jul 26 | Open-market buy · P | +2,420 | $4.49 | +$10.9K | 215,000 |
| King Thomas Braxton | Pres & CEO | Jul 25 | Open-market buy · P | +12,580 | $4.50 | +$56.6K | 212,580 |
| King Thomas Braxton | Pres & CEO | Jul 24 | Open-market buy · P | +25,000 | $4.48 | +$112K | 200,000 |
| Moreland Darl | SVP, Quality | Mar 29 | Grant / award · A | +43,750 | $4.42 | +$193K | 47,299 |
| King Thomas Braxton | Pres & CEO | Mar 29 | Grant / award · A | +175,000 | $4.42 | +$774K | 175,000 |
Loading...
